Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

ClinicalTrials.gov ID: NCT01106430

Public ClinicalTrials.gov record NCT01106430. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 4:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Double-blind, Randomised, Active-controlled, Parallel Group Study to Assess the Time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) Who Have Had an Inadequate Response to Methylphenidate Therapy

Study identification

NCT ID
NCT01106430
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
267 participants

Conditions and interventions

Interventions

  • Atomoxetine Hydrochloride Drug
  • Lisdexamfetamine Dimesylate Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 27, 2010
Primary completion
Jul 18, 2012
Completion
Jul 18, 2012
Last update posted
Jun 10, 2021

2010 – 2012

United States locations

U.S. sites
34
U.S. states
25
U.S. cities
34
Facility City State ZIP Site status
Harmonex Neuroscience Research, Inc Dothan Alabama 36303
Clinical Study Centers, LLC Little Rock Arkansas 72205
Shanti Clinical Trials Colton California 92324
Psychiatric Centers at San Diego Feighner Research San Diego California 92108
Elite Clinical Trials, Inc. Wildomar California 92595
Sarkis Clinical Trials Gainesville Florida 32607
Amedica Research Institute, Inc. Hialeah Florida 33013
Fidelity Clinical Research, Inc. Lauderhill Florida 33319
Clinical Neuroscience Solutions, INC Orlando Florida 32806
Northwest Behavioral Research Center Roswell Georgia 30076
Capstone Clinical Research Libertyville Illinois 60048
Baber Psychiatric Associates Naperville Illinois 60563
Clinco Terre Haute Indiana 47802
Heartland Research Associates, LLC Wichita Kansas 67207
Four Rivers Clinical Research, Inc Paducah Kentucky 42003
Louisianna Research Associates New Orleans Louisiana 70114
Office of Marc Hertzman, MD, PC Rockville Maryland 20852
Rochester Center for Behavioral Medicine Rochester Hills Michigan 48307
Midwest Research Group/Saint Charles Psychiatric Associates Saint Charles Missouri 63301
Premier Psychiatric Research Institute, LLC Lincoln Nebraska 68526
Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas Nevada 89128
Children's Specialized Hospital Toms River New Jersey 08755
Richmond Behavioral Associates Staten Island New York 10312
Triangle Neuropsychiatry, PLLC Durham North Carolina 27707
Innovis Health Fargo North Dakota 58103
IPS Research Company Oklahoma City Oklahoma 73103
Cyn3rgy Research Gresham Oregon 97030
CRI Worldwide, LLC Kirkbride Division Philadelphia Pennsylvania 19139
Future Search Clinical Trials Austin Texas 78731
Red Oak Psychiatry Association, PA Houston Texas 77090
Western Clinical Investigations Lubbock Texas 79423
Cerebral Research, LLC San Antonio Texas 78247
Lifetree Clinical Research Salt Lake City Utah 84106
Eastside Therapeutic Resource Kirkland Washington 98033

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01106430, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 10, 2021 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01106430 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →